Nimbus Discovery Inks $24M Series A

Biopharma company Nimbus Discovery has closed on a $24 million Series A round co-led by Atlas Venture, SR One, and Lilly Ventures. Existing investor, Bill Gates, also participated, the company said. Nimbus uses computational technology to discover medicines for difficult-to-drug diseases, and will use the infusion of capital to accelerate its existing development programs. The company closed on an undisclosed amount of seed financing in March.

North AmericaUSBriefs